Times Square Capital Management, LLC Xenon Pharmaceuticals Inc. Transaction History
Times Square Capital Management, LLC
- $6.51 Billion
- Q4 2024
A detailed history of Times Square Capital Management, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Times Square Capital Management, LLC holds 848,850 shares of XENE stock, worth $33 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
848,850
Previous 778,293
9.07%
Holding current value
$33 Million
Previous $30.6 Million
8.65%
% of portfolio
0.51%
Previous 0.47%
Shares
9 transactions
Others Institutions Holding XENE
# of Institutions
218Shares Held
72MCall Options Held
152KPut Options Held
3.6K-
Avoro Capital Advisors LLC New York, NY5.67MShares$220 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$176 Million1.73% of portfolio
-
Wellington Management Group LLP Boston, MA3.78MShares$147 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$113 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$112 Million0.06% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.42B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...